Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Selexipag is dosed at 0.01–0.05 mg/kg PO q12h in dogs, per Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use.. Selexipag is used in dogs for Pulmonary hypertension (add-on therapy). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Selexipag in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Uptravi
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.01–0.05 mg/kg | q12h | Long-term; slow dose titration required | Pulmonary hypertension (add-on therapy) | Extrapolated | Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use. |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Selective prostacyclin (IP) receptor agonist that causes pulmonary vasodilation and inhibits vascular smooth muscle proliferation. Active metabolite has high IP selectivity.
Headache, jaw pain, diarrhea, nausea. Slow dose titration required. Investigational for canine pulmonary hypertension as add-on to sildenafil.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Selexipag dose range in dogs, with cited source references: PO 0.01–0.05 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Selexipag in dogs: PO.
Cited course lengths for Selexipag in dogs include: Long-term; slow dose titration required. Duration depends on the indication — match it to the specific dose rule in the table above.
Selexipag is indicated in dogs for: Pulmonary hypertension (add-on therapy).
These are general warnings for Selexipag across species; consult the dog dosing table above for species-specific guidance. Headache, jaw pain, diarrhea, nausea. Slow dose titration required. Investigational for canine pulmonary hypertension as add-on to sildenafil.
Why a species-specific page? Selexipag pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.